KP Tissue (KPT) Price Target Lowered to C$10.00 at Royal Bank of Canada

KP Tissue (TSE:KPT) had its price objective reduced by Royal Bank of Canada from C$11.00 to C$10.00 in a research note issued to investors on Friday morning. They currently have an outperform rating on the stock.

A number of other equities analysts have also recently commented on the stock. National Bank Financial cut their target price on shares of KP Tissue from C$9.50 to C$7.00 and set a sector perform rating on the stock in a report on Tuesday, October 23rd. TD Securities cut their target price on shares of KP Tissue from C$11.50 to C$11.00 in a report on Friday, August 10th. Desjardins cut shares of KP Tissue from a buy rating to a hold rating and cut their target price for the company from C$12.50 to C$11.00 in a report on Friday, July 13th. Finally, CIBC lowered shares of KP Tissue from an outperform rating to a neutral rating and set a C$10.00 price objective on the stock. in a research report on Thursday, July 12th. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company has an average rating of Hold and a consensus price target of C$9.58.

Shares of KP Tissue stock traded up C$0.18 during trading on Friday, reaching C$7.54. The company’s stock had a trading volume of 19,100 shares, compared to its average volume of 17,128. KP Tissue has a fifty-two week low of C$6.58 and a fifty-two week high of C$14.44.

KP Tissue (TSE:KPT) last announced its earnings results on Thursday, August 9th. The company reported C$0.08 EPS for the quarter, meeting analysts’ consensus estimates of C$0.08. As a group, equities research analysts expect that KP Tissue will post 0.527854234984183 EPS for the current fiscal year.

In other news, insider Ii Joseph Kruger acquired 3,000 shares of the stock in a transaction that occurred on Tuesday, August 28th. The shares were purchased at an average cost of C$9.88 per share, for a total transaction of C$29,640.00. Over the last quarter, insiders purchased 5,700 shares of company stock worth $56,565.

About KP Tissue

KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. The company operates through three segments: Consumer Products, Away-From-Home, and Other. It offers bathroom and facial tissues, paper towels, and paper towels and napkins, as well as disposable wiping products and washroom dispensing systems.

Recommended Story: Diversification For Individual Investors

Analyst Recommendations for KP Tissue (TSE:KPT)

Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with's FREE daily email newsletter.

Leave a Reply